LeBel Carl
- SEC CIK
- 0001439275
No open-market purchases or sales filed in the past year.
Current role at each company
- KRRO Korro Bio, Inc.Chief Development Officeras of Jan 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists LeBel Carl as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2022 (view filing) | Jul 6 | 1 day | LeBel CarlChief Development Officer | SSale | −4.42K | $1.52 | −$6.72K | −14.4%26.3K after | |
| Feb 23, 2022 (view filing) | Feb 18-22 | 5 days | LeBel CarlChief Development Officer | SSale | −2.04K | $3.69 | −$7.54K | −15.5%11.1K after | 2 lots |
| Feb 18, 2022 (view filing) | Feb 16-17 | 2 days | LeBel CarlChief Development Officer | SSale | −1.73K | $4.31 | −$7.46K | −11.6%13.2K after | 2 lots |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | LeBel CarlChief Development Officer | SSale | −844 | $4.33 | −$3.65K | −5.4%14.9K after |